Viewing Study NCT02359851


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-02-19 @ 5:15 PM
Study NCT ID: NCT02359851
Status: TERMINATED
Last Update Posted: 2019-09-18
First Post: 2015-02-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pembrolizumab in Treating Patients With Advanced Uveal Melanoma
Sponsor: Vanderbilt-Ingram Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage IIIA Uveal Melanoma View
None Stage IIIB Uveal Melanoma View
None Stage IIIC Uveal Melanoma View
None Stage IV Uveal Melanoma View
Keywords: